Company Filing History:
Years Active: 2013
Title: Stephanie Wigginton: Innovator in Hemoglobin Research
Introduction
Stephanie Wigginton is a notable inventor based in Papillion, NE (US). She has made significant contributions to the field of medical research, particularly in the area of glycated hemoglobin. Her work is essential for improving diagnostic methods related to blood glucose levels.
Latest Patents
Wigginton holds a patent for a method of preparing controls for glycated hemoglobin S-A1c derived from healthy blood cells. This invention provides a method that involves contacting red blood cells in a suspension medium containing mannose. The conditions are set to increase the concentration of S-A1c glycated hemoglobin to greater than about 6 percent by weight of the hemoglobin in the red blood cells. The method is preferably performed in an aqueous suspension medium at ambient temperatures ranging from 18°C to about 23°C.
Career Highlights
Wigginton is associated with Streck, Inc., a company known for its innovations in the field of medical diagnostics. Her work has contributed to advancements in the accuracy and reliability of hemoglobin testing, which is crucial for diabetes management.
Collaborations
Some of her notable coworkers include Kausik Das and Gary D Krzyzanowski. Their collaborative efforts have further enhanced the research and development initiatives at Streck, Inc.
Conclusion
Stephanie Wigginton's contributions to hemoglobin research exemplify the impact of innovative thinking in medical diagnostics. Her patent and work at Streck, Inc. highlight her role as a key figure in advancing healthcare technology.